万古霉素治疗药物监测咨询服务:剂量推荐报告与电话沟通的经验
本文描述了某万古霉素治疗药物监测咨询服务在18个月内的活动,该服务结合剂量预测软件与临床专业经验。共为182个疗程提供408份剂量报告,其中57%建议调整剂量,82.8%的调整建议被治疗团队接受。
要点
- 剂量预测软件结合临床经验可优化万古霉素AUC24导向给药。
- 多数剂量调整建议被临床团队接受,且剂量报告发布与达标相关。
- 软件整合有望减少错误和工作人员工作量。
核心结论
- 使用剂量预测软件结合临床专业经验的咨询服务可促进万古霉素治疗目标的达成。
研究设计与样本
- 对某万古霉素治疗药物监测咨询服务进行18个月的描述性研究,共涉及182个疗程的408份剂量报告。
主要发现
- 57%的剂量报告建议调整剂量,82.8%(193/233)的推荐调整被治疗团队接受。
- 125个疗程未发布剂量报告,原因包括患者处于重症监护室或服务错误。
- 每月约分配26.6小时工作人员时间用于服务活动。
临床怎么用
- 临床药学智能体可借鉴该服务模式,利用剂量预测软件辅助万古霉素AUC24导向剂量调整,并生成剂量推荐报告供临床团队参考。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Dose-prediction software is recommended to enable area under the curve over 24 h (AUC24 )-guided dosing of the antibiotic vancomycin. However, uncertainty remains about how best to implement software in the clinic. We describe the activity, over 18 months, of a consultative therapeutic drug monitoring Advisory Service (the Service) for vancomycin that used dose-prediction software alongside clinical expertise, identifying factors that influence attainment of therapeutic targets. Of the 408 vancomycin dose reports provided for 182 courses of therapy, most (57%) recommended a dose change. The majority (82.8%, 193/233) of recommended dose adjustments were accepted by treating teams. A dose report was not published for 125 courses of therapy, with reasons including patient in intensive care unit or service error. An estimated 26.6 h of staff time was allocated to Service activities each month. Publication of a dose report facilitated attainment of therapeutic targets (P = .002). Software integration could improve Service outcomes, avoiding errors and reducing staff workload.
引用
- Carland JE, Stacy AE, Schaffer AL, et al. Blood, dose recommendation reports and phone calls: Experiences of a therapeutic drug monitoring advisory service for vancomycin. Br J Clin Pharmacol. 2023. PMID: 36662777. doi:10.1111/bcp.15668
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。